C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2011
11/24/2011	CA2799556A1 Compounds
11/24/2011	CA2799520A1 Novel processes
11/23/2011	EP2388842A1 Organic electroluminescent element
11/23/2011	EP2388250A1 4-Pyrimidinone derivatives and their use as anti-HIV agents
11/23/2011	EP2388249A1 HIV inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives
11/23/2011	EP2387566A1 Process for the preparation of rosuvastatin
11/23/2011	EP2387565A2 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
11/23/2011	EP2387440A2 Quinazolinone derivatives useful as vanilloid antagonists
11/23/2011	EP2283011B1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
11/23/2011	CN102256968A Heterocyclic antiviral compounds
11/23/2011	CN102250075A 2,4-disubstituted quinazoline compounds and preparation method, medicinal composition and application thereof
11/23/2011	CN102250020A Method for preparing N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-dipyridine]-4-yl]-4-tertiary butyl-benzsulfamide
11/23/2011	CN102250019A (Thio) barbituric acid compound and application thereof
11/23/2011	CN102250018A Preparation method of 2-ehtyoxyl-4,6-dyhydroxypyrimidine
11/23/2011	CN102250017A Synthesizing method of dicyclanil
11/23/2011	CN102250016A Method for preparing 4,5,6-trichloropyrimidine
11/23/2011	CN102250015A Penta-substituted tetrahydropyridine capable of carrying out aggregation-induced emission as well as preparation method and application thereof
11/23/2011	CN101618345B Method for static decompression recovery and recycle of catalyst in synthetic reaction of 2, 4, 6-trichloropyrimidine
11/22/2011	US8063213 Reacting (1-6C)alkyl ester of (E)-(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4R,6S)-2,2-dimethyl[1,3]dioxan-4-yl) acetic acid with hydrochloric acid, salt formation with sodium or potassium hydroxide, basification, desolventization, salt exchange
11/22/2011	US8063211 Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
11/22/2011	US8063057 Multicyclic amino acid derivatives and methods of their use
11/22/2011	US8063056 Anti-cancer cyclopenta [g]quinazonline compounds
11/22/2011	US8063050 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11/22/2011	US8063049 Inhibitors of MEK
11/22/2011	CA2509151C Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
11/22/2011	CA2471974C Quinazolinone derivatives and their use as cb agonists
11/17/2011	WO2011143425A2 Compounds useful as inhibitors of atr kinase
11/17/2011	US20110282031 A1 adenosine receptor diagnostic probes
11/17/2011	US20110281900 Crystalline Pharmaceutical
11/17/2011	US20110281898 Phenoxiacetic acid derivatives
11/17/2011	US20110281893 Compound, synthesis, composition and uses thereof
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/17/2011	US20110281873 Pyrimidine Compounds and Methods of Making and Using Same
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281838 5-alkynyl-pyrimidines
11/16/2011	EP2386547A1 Multicyclic amino acid derivatives and methods of their use
11/16/2011	EP1891018B1 Modulators of atp-binding cassette transporters
11/16/2011	EP1746999B1 4-phenylamino-quinazolin-6-yl-amides
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	EP1481971B1 Process for producing 4-aminoquinazoline compound
11/16/2011	CN102245580A Novel substrates of O6-alkylguanine-DNA alkyltransferase and mutants thereof
11/16/2011	CN102245574A Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
11/16/2011	CN102245573A Heteroaryl derivatives as cftr modulators
11/16/2011	CN101696192B Pyrimidine substituted acrylic ester compounds with fungicidal activities and preparation method thereof
11/15/2011	US8058434 Compositions to effect neuronal growth
11/15/2011	US8058433 Crystalline pharmaceutical
11/15/2011	US8058432 Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of derivatives
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058279 Insecticidal pyrimidinyl aryl hyrdrazones
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2450473C Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/15/2011	CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/15/2011	CA2385736C Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/10/2011	WO2011139295A1 Small molecule inhibitors of protein kinases
11/10/2011	WO2011090323A3 Novel preparation method of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl)-n,n-dimethylacetamide
11/10/2011	US20110275813 Bicylic 1,3-diones and Their Use as Insecticides, Acaricides and/or Fungicides
11/10/2011	US20110275812 Process for the preparation and purification of etravirine and intermediates thereof
11/10/2011	US20110275810 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
11/10/2011	US20110275797 N-acyl anthranilic acid derivative or salt thereof
11/10/2011	US20110275652 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents
11/10/2011	US20110275645 Small Molecules for Inhibition of Protein Kinases
11/10/2011	US20110275643 Aroylquinoline compounds
11/10/2011	US20110275641 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275635 Small molecule inhibitors of nads, namnat, and nmnat
11/10/2011	US20110275590 Conjugates for cancer therapy and diagnosis
11/09/2011	EP2385139A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385138A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385137A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2384322A1 Pyrimidine derivatives and the use thereof for combating undesired plant growth
11/09/2011	EP2384321A1 Pyrimidine derivatives and the use thereof for combating undesired plant growth
11/09/2011	EP2197853B1 Insecticidal pyrimidinyl aryl hydrazones
11/09/2011	EP1673085B1 C-met modulators and methods of use
11/09/2011	EP1658263B9 Novel aminobenzophenone compounds
11/09/2011	EP1651620B1 Piperazine derivatives and their use as therapeutic agents
11/09/2011	CN1878760B Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s)-3, 5-dihydroxyhept-6-enoicacid] calcium salt
11/09/2011	CN102234271A Aryl (alkyl) amino dithio formate compounds, and preparation method and application thereof
11/09/2011	CN102234266A Preparation and application of tetrahydrofolic acid ring-opened analogs with aziridine structure
11/09/2011	CN102234250A Antitumor bioactive alkaloid compound in Agelas clathrodes
11/09/2011	CN102234249A N-(hexahydropyrimidine-1,3-diyl)-di-L-amino acid methyl ester, preparation method thereof and application thereof
11/09/2011	CN101619042B Method for synthesizing aromatic pyrimidine-4(3H)-ketone compounds
11/09/2011	CN101420985B Test agent for diagnosing dyspepsia
11/08/2011	US8053440 To regulate the expression of apolipoprotein A-I; atherosclerosis; improved pharmacological properties; 3-(4-hydroxy-3,5-dimethylphenyl)-6,8-dimethoxyisoquinolin-1(2H)-one; to reduce cholesterol levels; agonists
11/08/2011	US8053439 Benzophenone derivatives useful for inhibiting formation of microtubule
11/08/2011	US8053434 Kinase inhibitors and their uses
11/08/2011	US8053039 Polymerizable dichroic azo dyes
11/08/2011	CA2618393C Bis-aryl amide compounds and methods of use
11/08/2011	CA2524069C Substituted dihydroquinazolines
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/03/2011	WO2011137342A1 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites
11/03/2011	WO2011137088A1 Herbicidal uracils
11/03/2011	WO2011136095A1 Treatment agent for decomposition of chemical substance which comprises persulfuric acid salt and silver complex, and method for decomposition of chemical substance using same
11/03/2011	WO2011104725A3 Intermediates for the preparation of hmg-coa reductase inhibitors and processes for the preparation thereof
11/03/2011	WO2011075699A3 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/03/2011	WO2011062437A3 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/03/2011	US20110269970 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
11/03/2011	US20110269961 Process for synthesis of phenoxy diaminopyrimidine derivatives
11/03/2011	US20110269785 Substituted 2-Aminoacetamides and the Use Thereof
11/03/2011	US20110269784 Use of tetrahydropyrimidines

1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 427